Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
new york
11
×
clinical trials
life sciences
national blog main
new york blog main
new york top stories
boston blog main
boston top stories
amgen
biotech
inclisiran
medicine
national top stories
regeneron pharmaceuticals
sanofi
alnylam pharmaceuticals
cholesterol
e-cigarette
fda
gear
pcsk9
pcsk9 inhibitors
politics
praluent
repatha
san francisco blog main
san francisco top stories
the medicines co.
vaping
1
acute migrane
advertising
agios pharmaceuticals
ai impact tour
alirocumab
allegations
america
attorney general
bain capital
ban
What
new
york
drug
medicines
cholesterol
medco
available
company
fda
ipo
lowering
marketing
state
today
twice
u.s
aces
acquire
activity
agreed
aim
ai’s
alleged
analytics
andrew
announced
appliances
ashley
attorney
away
bank
bans
bear
beecy
big
billion
biotech
bird
bringing
brings
Language
unset
11
×
Current search:
" new york "
×
unset
×
@venturebeat.com
2 months ago
Unlocking AI’s potential: Insights from Citi, NewYork-Presbyterian and Microsoft execs on Feb. 29
@techdirt.com
1 year ago
New York Becomes The First State To Pass A ‘Right To Repair’ Law
@techcrunch.com
1 year ago
Despite regulatory hurdles, these 4 US cannabis investors are planting seeds for tomorrow
@engadget.com
4 years ago
Headspace offers free mindfulness exercises to help with stress
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@engadget.com
4 years ago
NY Attorney General sues Juul for deceptive marketing
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@engadget.com
4 years ago
New York state bans sales of flavored e-cigarettes
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs